GFPT1 and prostate carcinoma: Interestingly, the expression of both GFPT1 and UAP1 was increased by ∼50% in AR-positive prostate cancer cell lines LNCaP and VCaP compared to normal prostate cells PNT2 and RWPE-1 (Fig. 1A).